Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBOFLAVIN 5^-PHOSPHATE: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

39.6%
Female
60.4%
Male

Age Information

The average age of patients reporting adverse events with RIBOFLAVIN 5^-PHOSPHATE is 34.8 years.

Geographic Distribution

The majority of adverse event reports for RIBOFLAVIN 5^-PHOSPHATE originate from US.

Report Summary & Outcomes

244
Total Reports
244
As Primary/Secondary Suspect
9
Deaths Reported
13
Hospitalizations
8
Life-Threatening
9
Disabilities

Reporting Timeline

First adverse event report: 20150101. Most recent report: 20250915. View full timeline →

More About RIBOFLAVIN 5^-PHOSPHATE

RIBOFLAVIN 5^-PHOSPHATE Full Profile Reports by Year Drug Interactions